Gruss & Co., LLC Ab Cellera Biologics Inc. Transaction History

Gruss & Co., LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 02, 2023	SELL	$5.66 - $7.59 $382,050 - $512,325	-67,500 Reduced 40.3%	100,000 $646,000
Q1 2023 May 11, 2023	SELL	$7.31 - $11.18 $642,549 - $982,722	-87,900 Reduced 34.42%	167,500 $1.26 Million
Q4 2022 Feb 10, 2023	SELL	$9.48 - $14.52 $504,051 - $772,028	-53,170 Reduced 17.23%	255,400 $2.59 Million
Q3 2022 Oct 21, 2022	SELL	$9.2 - $13.68 $507,913 - $755,245	-55,208 Reduced 15.18%	308,570 $3.05 Million
Q2 2022 Jul 29, 2022	BUY	$5.72 - $10.65 $444,890 - $828,335	77,778 Added 27.2%	363,778 $3.87 Million
Q1 2022 Apr 29, 2022	SELL	$7.46 - $14.14 $1.05 Million - $1.99 Million	-140,966 Reduced 33.02%	286,000 $2.79 Million
Q4 2021 Jan 31, 2022	SELL	$12.99 - $17.73 $44,698 - $61,008	-3,441 Reduced 0.8%	426,966 $6.11 Million
Q3 2021 Oct 28, 2021	BUY	$14.85 - $21.34 $6.39 Million - $9.18 Million	430,407 New	430,407 $8.63 Million

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Gruss & Co., LLC, based on Form 13F filings with the SEC.

Stay updated on Gruss & Co., LLC with notifications on news.